Large GWAS study in East Asian individuals with SLE

Comment on: Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Xianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu et al. Ann Rheum Dis 2020 Dec 3;annrheumdis-2020-219209. doi: 10.1136/annrheumdis-2020-219209. Online ahead of print.

Commented by: Maria G. Tektonidou, First Department of Propaedeutic Internal Medicine, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, Greece.

Over the past decades, an enormous progress has been made in the identification of genetic factors that contribute to the development of SLE (1). Despite the fact that more than 100 genetic loci have been found to be more prevalent in SLE compared to the general population, these explain only about 30% of SLE heritability. In many of the GWAS conducted, there is low representation of specific groups like East Asians although epidemiological studies showed a high prevalence of SLE in these groups (2, 3). Given the genetic and phenotypic differences between Europeans and East Asians, Yin et al conducted a large genome-wide meta-analysis (GWAS) study in East Asian individuals with SLE.

In this study, 3 different case-control cohorts from 3 East Asian countries (China, Korea and Japan) were combined, reaching a total number of 10.029 SLE cases and 180.167 healthy controls. Additional data from 3348 SLE cases and 14 826 controls published previously in East Asian SLE GWAS were analysed. In total, 13.377 SLE cases and 194.993 controls were included in the meta-analysis; 26.379 genetic variants in 113 loci reached the level of statistical significance for GWAS (p<5×10−8) and 46 of them were novel. Noteworthy, in 7 of these novel loci, minor allele frequency (MAF) of the lead SNP was 10-times higher in East Asians compared to Europeans.

New exonic variants were identified at two novel (CHD23 and LRRK1) and three known (CSK, IKBKB and TYK2) loci. In the latter, the new exonic variants were not correlated with those previously reported in the same genes. From the exonic variants reported, those pertain to the newly identified loci (CHD23 and LRRK1) are implicated in cell migration, B-cell proliferation and NFκΒ activation. Using GCTA analysis based on linkage disequilibrium (LD) estimated from 7021 unrelated Chinese non-SLE individuals, 233 independent association signals were recorded. From these, 110 putative causal variants for 57 SLE loci were identified and 10 [four known: ATXN2,BACH2, DRAM1/WASHC3 and NCF2 and six novel: 17p13.1, ELF3, GTF2H1, LRRK1, LOC102724596/PHB and STIM1) most likely putative causal variants with posterior probability ≥0.8 were further prioritized. In addition, significant positive genetic correlations were found between SLE and two other autoimmune disorders, rheumatoid arthritis (rg =0.437) and Graves’ disease (rg=0.318). Significant genetic correlations were also found between SLE and albumin/globulin ratio (rg =−0.242) and non-albumin protein(rg=0.238).

In summary, this is the largest GWAS study for SLE in East Asian populations identifying 46 novel susceptibility loci for SLE risk that can also help to better understand the phenotypic diversity of SLE between Asians and Europeans. A limitation of the study highlighted also by the authors is the small linkage disequilibrium reference panel from single population in the in the Bayesian statistical fine-mapping analysis. The study demonstrated for the first time significant genetic correlations between SLE, albumin/globulin ratio and higher serum globulin suggesting a common pathway underlying the SLE risk and kidney function.

References

  1. Bentham J, Morris DL, Graham DSC, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 2015;47:1457–6
  2. Morris DL, Yujun Sheng Y, Yan Zhang Y, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet. 2016 Aug;48(8):940-946. doi: 10.1038/ng.3603.
  3. Osio-Salido E, Manapat-Reyes H: Epidemiology of systemic lupus erythematosus in Asia. Lupus 2010; 19: 1365–1373.

A high burden of SLE risk genes is associated with persistent activation of the interferon system in patients with lupus.

Comment on: Single-cell RNA-seq reveals a persistent interferon signature in immune cells from  systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial  treatment. J Autoimmun. 2026 May 12:161:103575. doi: 10.1016.  Commented by: Lars Rönnblom, Department of Medical Sciences, Uppsala University, Sweden.    Genome-wide association studies have identified more than 300 loci associated to increased risk for  SLE. For the majority of the gene variants in these loci the functional consequences in the SLE disease  process are unknown. However, a large proportion of identified risk genes are connected to the  interferon signaling pathway and contribute to the interferon signature in SLE. Calculating a polygenic  risk score (PRS) is a method to quantify the cumulative genetic burden in a single patient and studies  have shown that patients with a high PRS have a more severe disease phenotype with increased  organ damage and reduced survival, compared to individuals with a low PRS.   Antimalarial therapy is a well-established treatment of SLE and have shown efficacy in a large  proportion of patients. The therapeutic effect is partly mediated by down regulation of the activated  interferon system, which is connected to clinical response. However, despite therapeutic  concentrations of hydroxychloroquine, many patients still have flares and accumulation of organ  damage. The main objective of the present study was therefore to clarify if antimalarial treatment has  different effects in patients with a high or a low PRS.  SLE patients in remission with a high or a low PRS were compared in gene expression profile at single  cell level on peripheral blood mononuclear cells. A total of 6 healthy controls and 16 matched  patients treated with similar antimalarial doses, but no corticosteroids, were investigated. On  average, 9636 cells were analyzed from each donor and 2724 genes detected per cell. Despite similar  clinical picture, patients with a high PRS had a prominent interferon signature across multiple  immune cell types, compared to patients with a low PRS who had a weak expression of interferon  stimulated genes only in monocytes. Pathway analysis revealed that the interferon signaling pathway 

Leggi Tutto »